Literature DB >> 23540661

Strategies for isolating and enriching cancer stem cells: well begun is half done.

Jiang-Jie Duan1, Wen Qiu, Sen-Lin Xu, Bin Wang, Xian-Zong Ye, Yi-Fang Ping, Xia Zhang, Xiu-Wu Bian, Shi-Cang Yu.   

Abstract

Cancer stem cells (CSCs) constitute a subpopulation of cancer cells that have the potential for self-renewal, multipotent differentiation, and tumorigenicity. Studies on CSC biology and CSC-targeted therapies depend on CSC isolation and/or enrichment methodologies. Scientists have conducted extensive research in this field since John Dick's group successfully isolated CSCs based on the expression of the CD34 and CD38 surface markers. Progress in CSC research has been greatly facilitated by the enrichment and isolation of these cells. In this review, we summarize the current strategies used in our and other laboratories for CSC isolation and enrichment, including methods based on stem cell surface markers, intracellular enzyme activity, the concentration of reactive oxygen species, the mitochondrial membrane potential, promoter-driven fluorescent protein expression, autofluorescence, suspension/adherent culture, cell division, the identification of side population cells, resistance to cytotoxic compounds or hypoxia, invasiveness/adhesion, immunoselection, and physical property. Although many challenges remain to be overcome, it is reasonable to believe that more reliable, efficient, and convenient methods will be developed in the near future.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23540661      PMCID: PMC3730373          DOI: 10.1089/scd.2012.0613

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  213 in total

1.  CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer.

Authors:  Matthew J Meyer; Jodie M Fleming; Amy F Lin; S Amal Hussnain; Erika Ginsburg; Barbara K Vonderhaar
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

Review 2.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

3.  Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.

Authors:  Gong Zhang; Lei Ma; You-Ke Xie; Xiao-Bo Miao; Chuan Jin
Journal:  Mol Med Rep       Date:  2012-06-08       Impact factor: 2.952

4.  CD13 is a therapeutic target in human liver cancer stem cells.

Authors:  Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Masahisa Ohkuma; Ho Min Kim; Hirofumi Akita; Daisuke Takiuchi; Hisanori Hatano; Hiroaki Nagano; Graham F Barnard; Yuichiro Doki; Masaki Mori
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

5.  Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells.

Authors:  Han-Ching Tseng; Aida Arasteh; Avina Paranjpe; Antonia Teruel; Wendy Yang; Armin Behel; Jackelyn A Alva; Gina Walter; Christian Head; Tomo-o Ishikawa; Harvey R Herschman; Nicholas Cacalano; April D Pyle; No-Hee Park; Anahid Jewett
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

6.  Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture.

Authors:  Yirui Sun; Steven Pollard; Luciano Conti; Mauro Toselli; Gerardo Biella; Georgina Parkin; Lionel Willatt; Anna Falk; Elena Cattaneo; Austin Smith
Journal:  Mol Cell Neurosci       Date:  2008-03-18       Impact factor: 4.314

7.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

8.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

9.  Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples.

Authors:  Daniel J Pearce; David Taussig; Catherine Simpson; Kirsty Allen; Ama Z Rohatiner; T Andrew Lister; Dominique Bonnet
Journal:  Stem Cells       Date:  2005 Jun-Jul       Impact factor: 6.277

10.  26S proteasome activity is down-regulated in lung cancer stem-like cells propagated in vitro.

Authors:  Jing Pan; Qi Zhang; Yian Wang; Ming You
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

View more
  31 in total

Review 1.  Concise Review: Prostate Cancer Stem Cells: Current Understanding.

Authors:  Sergej Skvortsov; Ira-Ida Skvortsova; Dean G Tang; Anna Dubrovska
Journal:  Stem Cells       Date:  2018-08-27       Impact factor: 6.277

2.  Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.

Authors:  Raheleh Roudi; Zahra Madjd; Marzieh Ebrahimi; Ali Najafi; Alireza Korourian; Ahmad Shariftabrizi; Ali Samadikuchaksaraei
Journal:  Tumour Biol       Date:  2016-04-05

3.  In vitro characterization of CD133lo cancer stem cells in Retinoblastoma Y79 cell line.

Authors:  Rohini M Nair; Murali Ms Balla; Imran Khan; Ravi Kiran Reddy Kalathur; Paturu Kondaiah; Geeta K Vemuganti
Journal:  BMC Cancer       Date:  2017-11-21       Impact factor: 4.430

4.  Cancer Stem Cells in Tumor Modeling: Challenges and Future Directions.

Authors:  Elvan Dogan; Asli Kisim; Gizem Bati-Ayaz; Gregory J Kubicek; Devrim Pesen-Okvur; Amir K Miri
Journal:  Adv Nanobiomed Res       Date:  2021-06-23

5.  A preliminary study of the role of extracellular -5'- nucleotidase in breast cancer stem cells and epithelial-mesenchymal transition.

Authors:  Jiangang Yu; Xiaohong Liao; Luying Li; Lei Lv; Xiuling Zhi; Jerry Yu; Ping Zhou
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-09-26       Impact factor: 2.416

6.  Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.

Authors:  Efraín A Cermeño; Andrés J García
Journal:  Curr Stem Cell Rep       Date:  2016-02-09

7.  Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers.

Authors:  J-H Kim; A M Frantz; A L Sarver; B H Gorden Klukas; M Lewellen; T D O'Brien; E B Dickerson; J F Modiano
Journal:  Vet Comp Oncol       Date:  2017-11-20       Impact factor: 2.613

8.  Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma.

Authors:  Mariana Maier Gaelzer; Mariana Silva Dos Santos; Bárbara Paranhos Coelho; Alice Hoffman de Quadros; Fabrício Simão; Vanina Usach; Fátima Costa Rodrigues Guma; Patrícia Setton-Avruj; Guido Lenz; Christianne G Salbego
Journal:  Mol Neurobiol       Date:  2016-10-06       Impact factor: 5.590

Review 9.  Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors.

Authors:  Courtney L Jones; Anagha Inguva; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2021-03-04       Impact factor: 24.633

Review 10.  Cancer stem cells and strategies for targeted drug delivery.

Authors:  Jin Cao; Shubhmita Bhatnagar; Jiawei Wang; Xueyong Qi; Swayam Prabha; Jayanth Panyam
Journal:  Drug Deliv Transl Res       Date:  2020-10-23       Impact factor: 5.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.